BriaCell TherapeuticsBCTX
那斯達克 · USD
3.94
+0.30
(+8.24%)
收盤 07/11 03:59 (UTC+8)
盤後
3.99
+0.05
(+1.27%)
07/11 03:59 (UTC+8)
BriaCell TherapeuticsBCTX
3.94
+0.30
(+8.24%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 7,621 | 7,532 | 8,323 | 8,554 | 6,328 | 7,170 | 5,152 | - | - | 9,829 |
研發費用 | 5,967 | 6,054 | 6,684 | 7,110 | 4,810 | 5,685 | 3,665 | 4,405 | 7,658 | 8,257 |
推銷及管理費用 | 1,654 | 1,478 | 1,639 | 1,444 | 1,518 | 1,485 | 1,487 | 1,362 | 1,572 | 1,572 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -7,621 | -7,531 | -8,323 | -8,554 | -6,328 | -7,169 | -5,153 | -5,768 | -9,230 | -9,829 |
其他收入及費用 | 261 | 53 | 89 | 392 | 176 | 795 | -605 | 4,845 | - | -14,462 |
利息費用 | 243 | -243 | - | - | 79 | -79 | - | - | 261 | -12,976 |
稅前純益 | -7,173 | -7,235 | -8,233 | -8,117 | -6,162 | -6,295 | -5,758 | -1,198 | 1,729 | -11,316 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -7,165 | -7,222 | -8,198 | -8,091 | -6,127 | -6,291 | -5,802 | -1,214 | 1,716 | -11,295 |
基本每股稅後盈餘(元) | -0.99 | -2.58 | -4.35 | -20.29 | -16.42 | -23.31 | -2.18 | -0.07 | 1.07 | -7.09 |
稀釋每股稅後盈餘(元) | 0.85 | -2.23 | -4.35 | 4.89 | -12.73 | -21.68 | -2.18 | -0.67 | 1.12 | 1.64 |
基本平均股數(千股) | 7250.00 | 2802.00 | 1883.00 | - | 373.00 | 269.00 | 2664.00 | 17876.00 | 1598.00 | 1598.00 |
稀釋平均股數(千股) | 7250.00 | 2802.00 | 1883.00 | - | 373.00 | 269.00 | 2664.00 | 17183.00 | 1598.00 | 1598.00 |
還原基本每股稅後盈餘(元) | -0.99 | -2.58 | -4.35 | -20.29 | -16.42 | -23.31 | -32.67 | -0.07 | 16.10 | -106.40 |
還原稀釋每股稅後盈餘(元) | 0.85 | -2.23 | -4.35 | 4.89 | -12.73 | -21.68 | -32.67 | -10.08 | 16.80 | 24.60 |
還原基本平均股數(千股) | 7,250 | 2,802 | 1,883 | - | 373 | 269 | 177 | 17,876 | 106 | 106 |
還原稀釋平均股數(千股) | 7,250 | 2,802 | 1,883 | - | 373 | 269 | 177 | 17,183 | 106 | 106 |
EBITDA(千元) | -6,889 | -7,438 | -8,171 | -8,064 | -6,021 | -6,343 | -5,775 | -1,142 | 1,981 | -24,267 |